View Item 

Show simple item record

Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patients
dc.contributor.authorHeidelbaugh, Joel J.en_US
dc.contributor.authorInadomi, John M.en_US
dc.date.accessioned2010-06-01T19:45:03Z
dc.date.available2010-06-01T19:45:03Z
dc.date.issued2006-10en_US
dc.identifier.citationHeidelbaugh, Joel J.; Inadomi, John M. (2006). "Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patients." The American Journal of Gastroenterology 101(10): 2200-2205. <http://hdl.handle.net/2027.42/72884>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72884
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16952283&dopt=citationen_US
dc.format.extent188669 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights2006 by Am. Coll. of Gastroenterologyen_US
dc.titleMagnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patientsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumClinical Assistant Professor, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, and Medical Director, Ypsilanti Health Center, Ypsilanti, Michiganen_US
dc.contributor.affiliationotherGI Outcomes and Health Services Research, University of California, San Francisco, and Division of Gastroenterology, San Francisco General Hospital, San Francisco, Californiaen_US
dc.identifier.pmid16952283en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72884/1/j.1572-0241.2006.00839.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2006.00839.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceAnderberg B, Sjodahl R. Prophylaxis and management of stress ulcers. Scand J Gastroenterol 1985; 20 ( suppl 110 ): 101 – 4.en_US
dc.identifier.citedreference2.  American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999; 56: 347 – 79.en_US
dc.identifier.citedreferenceParente F, Cucino C, Gallus S, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1-month survey. Aliment Pharmacol Ther 2003; 17: 1503 – 6.en_US
dc.identifier.citedreferenceNardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118 – 22.en_US
dc.identifier.citedreferenceZink DA, Pohlman M, Barnes M, et al. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther 2005; 21: 1203 – 9.en_US
dc.identifier.citedreferenceMostafa G, Sing R, Matthews B, et al. The economic benefit of practice guidelines for stress ulcer prophylaxis. Am Surg 2002; 68: 146 – 50.en_US
dc.identifier.citedreferencePitimana-aree S, Forrest D, Brown G, et al. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med 1998; 24: 217 – 23.en_US
dc.identifier.citedreferenceDevlin JW, Claire KS, Dulchavsky SA, et al. Impact of stress ulcer prophylaxis guidelines on drug cost and frequency of major gastrointestinal bleeding. Pharmacotherapy 1999; 19: 452 – 60.en_US
dc.identifier.citedreferenceSchupp KN, Schrand LM, Mutnick AH. A cost-effectiveness analysis of stress ulcer prophylaxis. Ann Pharmacother 2003; 37: 631 – 5.en_US
dc.identifier.citedreferenceLaheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric-acid suppressive drugs. JAMA 2004; 292: 1955 – 60.en_US
dc.identifier.citedreferenceHanisch EW, Encke A, Naujoks F, et al. A randomized, double-blind trial for stress ulcer prophylaxis shows no evidence of increased pneumonia. Am J Surg 1998; 176: 453 – 7.en_US
dc.identifier.citedreferenceSung JJ. The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers. Gastroenterol Clin North Am 2003; 32 ( suppl 3 ): S11 – 23.en_US
dc.identifier.citedreferenceJung R, MacLaren R. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother 2002; 36: 1929 – 37.en_US
dc.identifier.citedreferenceCash BD. Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Crit Care Med 2002; 30 ( suppl 6 ): S373 – 8.en_US
dc.identifier.citedreferenceEstruch R, Pedrol E, Castells A, et al. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol 1991; 26: 819 – 26.en_US
dc.identifier.citedreferenceStrid H, Simren M, Bjornsson ES. Overuse of acid suppressant drugs in patients with chronic renal failure. Nephrol Dial Transplant 2003; 18: 570 – 5.en_US
dc.identifier.citedreferenceErstad BL, Jeffrey F, Barletta JF, et al. Survey of stress ulcer prophylaxis. Crit Care 1999; 3: 145 – 9.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2006.00839.x.pdf
Size:
184.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.